⁶⁴Cu/¹⁷⁷Lu-DOTA-diZD, a Small-Molecule-Based Theranostic Pair for Triple-Negative Breast Cancer

Medicine & Life Sciences

• 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid 100%
• Theranostic Nanomedicine 78%
• Triple Negative Breast Neoplasms 72%
• Radioisotopes 34%
• Vascular Endothelial Growth Factor Receptor 20%
• Therapeutics 9%
• Chelating Agents 9%
• Ionizing Radiation 8%
• Cold Temperature 7%
• Immunotherapy 7%
• Neoplasms 5%
• Survival 4%
• Growth 4%

Chemistry

• 1,4,7,10-tetraazacyclododecane 82%
• Radioisotope 52%
• Ionizing Radiation 14%
• Chelating Agent 11%
• Dose 9%
• Acid 4%